PRELUDE CAPITAL MANAGEMENT, LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 75 filers reported holding RECRO PHARMA INC in Q1 2019. The put-call ratio across all filers is 1.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2019$4,000
+33.3%
3370.0%0.00%
Q2 2019$3,000
-99.0%
337
-99.3%
0.00%
-100.0%
Q1 2019$300,000
-18.9%
51,261
-1.6%
0.02%
-32.0%
Q4 2018$370,000
+20.9%
52,076
+21.1%
0.02%
+38.9%
Q3 2018$306,000
+168.4%
42,995
+89.7%
0.02%
+157.1%
Q2 2018$114,000
-57.1%
22,665
-6.2%
0.01%
-63.2%
Q1 2018$266,000
+442.9%
24,165
+245.2%
0.02%
+280.0%
Q2 2017$49,000
-70.8%
7,000
-66.5%
0.01%
-75.0%
Q4 2016$168,000
+2000.0%
20,879
+2219.9%
0.02%
+1900.0%
Q4 2015$8,000
+60.0%
900
+125.0%
0.00%0.0%
Q3 2015$5,0004000.00%
Other shareholders
RECRO PHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders